These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone. Lazareno S; Nahorski SR Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377 [TBL] [Abstract][Full Text] [Related]
5. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors. Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917 [TBL] [Abstract][Full Text] [Related]
6. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum. Zahniser NR; Dubocovich ML J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559 [TBL] [Abstract][Full Text] [Related]
7. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions. List SJ; Seeman P Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314 [TBL] [Abstract][Full Text] [Related]
8. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum. Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398 [TBL] [Abstract][Full Text] [Related]
9. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates. Gundlach AL; Krstich M; Beart PM Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373 [TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of radioiodinated butyrophenones as radiotracer for dopamine receptor study. Nakatsuka I; Saji H; Shiba K; Shimizu H; Okuno M; Yoshitake A; Yokoyama A Life Sci; 1987 Oct; 41(17):1989-97. PubMed ID: 2959832 [TBL] [Abstract][Full Text] [Related]
11. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites. Leysen JE; Gommeren W J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046 [TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states. George SR; Watanabe M; Seeman P J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204 [TBL] [Abstract][Full Text] [Related]
13. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations. De Vries DJ; Beart PM Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565 [TBL] [Abstract][Full Text] [Related]
14. [3H]Spiperone labels non-cyclase-linked dopamine receptors in the ventral tegmental area of rat brain. Gundlach AL; McDonald D; Beart PM J Neurochem; 1982 Sep; 39(3):890-4. PubMed ID: 7097294 [TBL] [Abstract][Full Text] [Related]
15. [125I]Spiperone is not a useful ligand for studying the CHAPS solubilized dopamine D-2 receptor from rat striatum. Kilpatrick GJ; Jenner P; Marsden CD J Pharm Pharmacol; 1986 May; 38(5):406-8. PubMed ID: 2423678 [TBL] [Abstract][Full Text] [Related]
16. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions? Clements-Jewery S; Robson PA Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304 [No Abstract] [Full Text] [Related]
17. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390. O'Boyle KM; Waddington JL Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559 [TBL] [Abstract][Full Text] [Related]
18. In vivo [3H]spiperone binding to the rat hippocampal formation: involvement of dopamine receptors. Bischoff S; Bittiger H; Krauss J Eur J Pharmacol; 1980 Dec; 68(3):305-15. PubMed ID: 7202494 [TBL] [Abstract][Full Text] [Related]
19. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol. Hancock AA; Marsh CL Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230 [TBL] [Abstract][Full Text] [Related]
20. [125]I-spectramide: a novel benzamide displaying potent and selective effects at the D2 dopamine receptor. Sánchez-Roa PM; Grigoriadis DE; Wilson AA; Sharkey J; Dannals RF; Villemagne VL; Wong DF; Wagner HN; Kuhar MJ Life Sci; 1989; 45(19):1821-9. PubMed ID: 2531826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]